Search research articles
Contact Us
Filters
Showing results (1-10 of 12) with videos related to
Page
of 2
Sort By:
Medical Mycology
|
January 22, 2002
Capsule and melanin synthesis in Cryptococcus neoformans
D C McFadden, A Casadevall
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy
|
August 22, 2001
Resistance as a tool in the study of old and new drug targets in Toxoplasma
D C McFadden, M Camps, J C Boothroyd
Antimicrobial Agents and Chemotherapy
|
September 26, 1997
Use of Toxoplasma gondii expressing beta-galactosidase for colorimetric assessment of drug activity in vitro
D C McFadden, F Seeber, J C Boothroyd
Molecular and Biochemical Parasitology
|
May 10, 2000
Characterization of cytochrome b from Toxoplasma gondii and Q(o) domain mutations as a mechanism of atovaquone-resistance
D C McFadden, S Tomavo, E A Berry, et al.
Infection and Immunity
|
April 1, 1992
Mouse model for Pneumocystis carinii pneumonia that uses natural transmission to initiate infection
M A Powles, D C McFadden, L A Pittarelli, et al.
The Journal of Protozoology
|
November 1, 1991
Establishment of Pneumocystis carinii in various mouse strains using natural transmission to initiate infection
D C McFadden, M A Powles, L A Pittarelli, et al.
Infection and Immunity
|
January 24, 2006
Phenotypic switching in a Cryptococcus neoformans variety gattii strain is associated with changes in virulence and promotes dissemination to the central nervous system
N Jain, Li Li, D C McFadden, et al.
Infection and Immunity
|
November 1, 1994
Use of anti-CD4+ hybridoma cells to induce Pneumocystis carinii in mice
D C McFadden, M A Powles, J G Smith, et al.
The Journal of Protozoology
|
November 1, 1991
Treatment and prevention of Pneumocystis carinii pneumonia and further elucidation of the P. carinii life cycle with 1,3-beta-glucan synthesis inhibitor L-671,329
D M Schmatz, M Powles, D C McFadden, et al.
Antimicrobial Agents and Chemotherapy
|
June 1, 1994
Aerosolized L-693,989 for Pneumocystis carinii prophylaxis in rats
M A Powles, D C McFadden, P A Liberator, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 12) with videos related to
Sort By:
Page
of 2
Medical Mycology
|
January 22, 2002
Capsule and melanin synthesis in Cryptococcus neoformans
D C McFadden, A Casadevall
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy
|
August 22, 2001
Resistance as a tool in the study of old and new drug targets in Toxoplasma
D C McFadden, M Camps, J C Boothroyd
Antimicrobial Agents and Chemotherapy
|
September 26, 1997
Use of Toxoplasma gondii expressing beta-galactosidase for colorimetric assessment of drug activity in vitro
D C McFadden, F Seeber, J C Boothroyd
Molecular and Biochemical Parasitology
|
May 10, 2000
Characterization of cytochrome b from Toxoplasma gondii and Q(o) domain mutations as a mechanism of atovaquone-resistance
D C McFadden, S Tomavo, E A Berry, et al.
Infection and Immunity
|
April 1, 1992
Mouse model for Pneumocystis carinii pneumonia that uses natural transmission to initiate infection
M A Powles, D C McFadden, L A Pittarelli, et al.
The Journal of Protozoology
|
November 1, 1991
Establishment of Pneumocystis carinii in various mouse strains using natural transmission to initiate infection
D C McFadden, M A Powles, L A Pittarelli, et al.
Infection and Immunity
|
January 24, 2006
Phenotypic switching in a Cryptococcus neoformans variety gattii strain is associated with changes in virulence and promotes dissemination to the central nervous system
N Jain, Li Li, D C McFadden, et al.
Infection and Immunity
|
November 1, 1994
Use of anti-CD4+ hybridoma cells to induce Pneumocystis carinii in mice
D C McFadden, M A Powles, J G Smith, et al.
The Journal of Protozoology
|
November 1, 1991
Treatment and prevention of Pneumocystis carinii pneumonia and further elucidation of the P. carinii life cycle with 1,3-beta-glucan synthesis inhibitor L-671,329
D M Schmatz, M Powles, D C McFadden, et al.
Antimicrobial Agents and Chemotherapy
|
June 1, 1994
Aerosolized L-693,989 for Pneumocystis carinii prophylaxis in rats
M A Powles, D C McFadden, P A Liberator, et al.
Page
of 2